TAS2R60

gene
On this page

Also known as T2R60

Summary

TAS2R60 (taste 2 receptor member 60, HGNC:20639) is a protein-coding gene on chromosome 7q35, encoding Taste receptor type 2 member 60 (P59551). Receptor that may play a role in the perception of bitterness and is gustducin-linked.

This gene encodes a member of the bitter taste receptor family which belong to the G protein-coupled receptor superfamily and are predominantly expressed in taste receptor cells of the tongue and palate epithelia. This intronless taste receptor gene encodes a seven-transmembrane receptor protein, functioning as a bitter taste receptor. This gene is clustered together with eight other taste receptor genes on chromosome 7.

Source: NCBI Gene 338398 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 1 total — 1 pathogenic
  • Druggable target: yes — 1 molecules with ChEMBL bioactivity
  • MANE Select transcript: NM_177437

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20639
Approved symbolTAS2R60
Nametaste 2 receptor member 60
Location7q35
Locus typegene with protein product
StatusApproved
AliasesT2R60
Ensembl geneENSG00000185899
Ensembl biotypeprotein_coding
OMIM613968
Entrez338398

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000332690

RefSeq mRNA: 1 — MANE Select: NM_177437 NM_177437

CCDS: CCDS5885

Canonical transcript exons

ENST00000332690 — 1 exons

ExonStartEnd
ENSE00001317227143443453143444409

Expression profiles

Bgee: expression breadth broad, 17 present calls, max score 55.76.

Top tissues by expression

98 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099155.76gold quality
colonic epitheliumUBERON:000039755.47gold quality
mucosa of transverse colonUBERON:000499150.74gold quality
bone marrow cellCL:000209249.08gold quality
bloodUBERON:000017845.23gold quality
leukocyteCL:000073843.39gold quality
sural nerveUBERON:001548843.38gold quality
monocyteCL:000057642.71gold quality
vermiform appendixUBERON:000115440.37silver quality
granulocyteCL:000009437.86gold quality
skeletal muscle tissueUBERON:000113436.58gold quality
liverUBERON:000210736.55silver quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
placentaUBERON:000198736.30gold quality
ganglionic eminenceUBERON:000402335.49gold quality
tonsilUBERON:000237234.66gold quality
urinary bladderUBERON:000125534.03silver quality
muscle tissueUBERON:000238533.41gold quality
lymph nodeUBERON:000002933.34silver quality
right lobe of liverUBERON:000111433.15silver quality
skin of legUBERON:000151133.09gold quality
left uterine tubeUBERON:000130331.88silver quality
rectumUBERON:000105231.77gold quality
right uterine tubeUBERON:000130230.93gold quality
zone of skinUBERON:000001430.77gold quality
stromal cell of endometriumCL:000225529.87gold quality
fundus of stomachUBERON:000116029.57silver quality
calcaneal tendonUBERON:000370129.43gold quality
prefrontal cortexUBERON:000045129.40gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.38

Regulation

Is transcription factor: no

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriotas2r200.2ENSDARG00000074066
danio_reriotas2r200.1ENSDARG00000079880
mus_musculusTas2r135ENSMUSG00000056203
rattus_norvegicusTas2r135ENSRNOG00000026811

Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R46 (ENSG00000226761), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)

Protein

Protein identifiers

Taste receptor type 2 member 60P59551 (reviewed: P59551)

Alternative names: Taste receptor type 2 member 56

All UniProt accessions (1): P59551

UniProt curated annotations — full annotation on UniProt →

Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5.

Subcellular location. Membrane.

Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells.

Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.

Similarity. Belongs to the G-protein coupled receptor T2R family.

RefSeq proteins (1): NP_803186* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR007960TAS2RFamily

Pfam: PF05296

UniProt features (17 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P59551-F178.020.20

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 179

Function

Pathways and Gene Ontology

Reactome pathways

6 pathways

IDPathway
R-HSA-418594G alpha (i) signalling events
R-HSA-420499Class C/3 (Metabotropic glutamate/pheromone receptors)
R-HSA-162582Signal Transduction
R-HSA-372790Signaling by GPCR
R-HSA-388396GPCR downstream signalling
R-HSA-500792GPCR ligand binding

MSigDB gene sets: 26 (showing top): GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr7q35, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOBP_DETECTION_OF_CHEMICAL_STIMULUS

GO Biological Process (4): sensory perception of bitter taste (GO:0050913), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)

GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), bitter taste receptor activity (GO:0033038)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-4 pathways:

CategoryPathways
Signaling by GPCR2
GPCR downstream signalling1
GPCR ligand binding1
Signal Transduction1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
sensory perception of taste1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
G protein-coupled receptor activity1
signal transduction1
sensory perception of chemical stimulus1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
detection of chemical stimulus involved in sensory perception of bitter taste1
taste receptor activity1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

418 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TAS2R60PKD2L1Q9P0L9590
TAS2R60OR2M4Q96R27575
TAS2R60PKD1L3Q7Z443573
TAS2R60TAS1R1Q7RTX1532
TAS2R60TAS1R2Q8TE23532
TAS2R60TAS2R50P59544514
TAS2R60OR8H1Q8NGG4506
TAS2R60GPRC6AQ5T6X5504
TAS2R60TAS1R3Q7RTX0481
TAS2R60SCNN1DP51172480
TAS2R60OR5K2Q8NHB8470
TAS2R60OR6N1Q8NGY5448
TAS2R60GNAT3A8MTJ3447
TAS2R60OR7D4Q8NG98447
TAS2R60OR13F1Q8NGS4439

IntAct

4 interactions, top by confidence:

ABTypeScore
TAS2R60LRRK2psi-mi:“MI:0407”(direct interaction)0.440
TAS2R60DAPK1psi-mi:“MI:0407”(direct interaction)0.440
TAS2R60MFHAS1psi-mi:“MI:0407”(direct interaction)0.440

BioGRID (4): TAS2R60 (Reconstituted Complex), TAS2R60 (Reconstituted Complex), TAS2R60 (Reconstituted Complex), TAS2R60 (Negative Genetic)

ESM2 similar proteins: A0A0R4IM31, A0A0R4IP11, P59532, P59533, P59536, P59551, Q2AB83, Q4VHE7, Q5J3F6, Q5J3L4, Q5J3L7, Q5J3M3, Q5J3M9, Q5J3N1, Q5Y4Z0, Q645S2, Q645U0, Q645U6, Q645U7, Q645Y3, Q645Z0, Q645Z1, Q646A4, Q646A5, Q646B2, Q646C7, Q646D0, Q646D5, Q646E6, Q646E9, Q646F3, Q67ER9, Q67ES2, Q67ES7, Q697L2, Q697L3, Q697L4, Q697L5, Q697L6, Q7TQA6

Diamond homologs: P59529, P59536, P59551, Q5Y4Z0, Q645S2, Q645U1, Q645U2, Q645U6, Q645U7, Q645Y3, Q645Y4, Q645Z0, Q646A5, Q646B2, Q646B3, Q646C7, Q646D0, Q646D1, Q646E7, Q646E8, Q646F1, Q646F3, Q646G6, Q67ES2, Q67ES3, Q67ES7, Q7M720, Q7TQA7, Q7TQA9, Q7TQB0, Q7TQB9, Q9JKE7, Q9JKF0, Q9JKT7, Q9JKU0, Q9NYV7, P59530, P59532, P59534, P59537

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

1 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
144163GRCh38/hg38 7q34-35(chr7:141126407-145652221)x3Pathogenic

SpliceAI

245 predictions. Top by Δscore:

VariantEffectΔscore
7:143443541:T:TAdonor_gain0.9100
7:143443542:A:AAdonor_gain0.9100
7:143443554:C:Tdonor_gain0.9000
7:143444090:T:Gacceptor_gain0.8200
7:143443497:G:GTdonor_gain0.8000
7:143443619:A:Gdonor_gain0.8000
7:143444089:AT:Aacceptor_gain0.7900
7:143443672:ATGG:Adonor_gain0.7500
7:143444089:A:AGacceptor_gain0.7400
7:143443556:A:AGdonor_gain0.7300
7:143443490:C:Gdonor_gain0.7200
7:143444346:CAGCA:Cacceptor_gain0.6900
7:143444347:AGCAA:Aacceptor_gain0.6900
7:143443594:C:CGdonor_gain0.6800
7:143444345:TCAG:Tacceptor_gain0.6700
7:143443935:A:AGacceptor_gain0.6600
7:143443936:G:GGacceptor_gain0.6600
7:143444288:G:Aacceptor_gain0.6500
7:143443587:G:GGdonor_gain0.6300
7:143443586:A:AGdonor_gain0.6200
7:143443931:TCATA:Tacceptor_loss0.6200
7:143443935:AGG:Aacceptor_loss0.6200
7:143443936:G:GTacceptor_loss0.6200
7:143444344:TTCAG:Tacceptor_gain0.6100
7:143444348:G:Tacceptor_gain0.6100
7:143444348:GC:Gacceptor_gain0.6000
7:143444348:GCA:Gacceptor_gain0.6000
7:143444347:A:AGacceptor_gain0.5900
7:143444348:G:GGacceptor_gain0.5900
7:143444348:GCAA:Gacceptor_gain0.5800

AlphaMissense

2073 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:143443909:A:CS153R0.839
7:143443911:C:AS153R0.839
7:143443911:C:GS153R0.839
7:143444077:T:CF209L0.835
7:143444079:T:AF209L0.835
7:143444079:T:GF209L0.835
7:143444206:T:CF252L0.789
7:143444208:T:AF252L0.789
7:143444208:T:GF252L0.789
7:143444218:T:CF256L0.779
7:143444220:C:AF256L0.779
7:143444220:C:GF256L0.779
7:143443756:T:CF102L0.770
7:143443758:C:AF102L0.770
7:143443758:C:GF102L0.770
7:143443711:T:CF87L0.765
7:143443713:C:AF87L0.765
7:143443713:C:GF87L0.765
7:143443840:T:CF130L0.760
7:143443842:C:AF130L0.760
7:143443842:C:GF130L0.760
7:143443795:A:CS115R0.745
7:143443797:T:AS115R0.745
7:143443797:T:GS115R0.745
7:143443633:A:CS61R0.738
7:143443635:C:AS61R0.738
7:143443635:C:GS61R0.738
7:143443801:T:CF117L0.729
7:143443803:C:AF117L0.729
7:143443803:C:GF117L0.729

dbSNP variants (sampled 300 via entrez): RS1000747422 (7:143444041 C>T), RS1004448451 (7:143441974 T>G), RS1004903987 (7:143441703 T>A), RS1005203496 (7:143444711 A>G), RS1005501402 (7:143442961 G>A,C,T), RS1005863557 (7:143443074 A>G), RS1006681966 (7:143443140 C>A), RS1006698533 (7:143443949 T>C,G), RS1008641040 (7:143442731 C>T), RS1009436705 (7:143444730 G>A), RS1009852333 (7:143444666 C>A), RS1010977899 (7:143442355 A>G), RS1011468654 (7:143442660 T>A), RS1012637026 (7:143442955 C>A), RS1013213242 (7:143444338 C>T)

Disease associations

OMIM: gene MIM:613968 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL3309109 (SINGLE PROTEIN)

Molecules with ChEMBL bioactivity

1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 40,234 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).

MoleculeNamePhasePatents
CHEMBL434ISOPROTERENOL440,234

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Taste 2 receptors

ChEMBL bioactivities

1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
8.31EC504.9nMISOPROTERENOL

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
CGP 52608affects binding, increases reaction1
2-palmitoylglycerolincreases expression1
Aldehydesincreases expression1
Benzo(a)pyreneaffects methylation1
Endosulfandecreases expression1
Silicon Dioxidedecreases expression1
Valproic Aciddecreases methylation1

ChEMBL screening assays

5 unique, capped per target: 4 functional, 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL3361958BindingAgonist activity at human TAS2R60 expressed in U2OS cells by Ga16gust44 Clone 7A FLIPR/summary (Abse5) assayIdentification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). — Bioorg Med Chem Lett
CHEMBL4419025FunctionalAgonist activity at recombinant human N-terminal rat ST3 receptor-fused TAS2R60 expressed in HEK293T cells co-expressing Galpha16gust44 assessed as increase in intracellular calcium level at 100 uM by FLIPR assayMethods of identifying antagonists of the hTAS2R46 bitter taste receptor

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.